Celltrion Files Tocilizumab In US

Korean Biosimilars Giant Submits CT-P47 Actemra Rival To US FDA

 
• By Dave Wallace

Celltrion has become the latest firm to file for a tocilizumab biosimilar in the US, submitting its CT-P47 candidate to the FDA.

Tocilizumab injection syringe
Celltrion has filed its tocilizumab biosimilar in the US • Source: Shutterstock

More from Biosimilars

More from Products